Upstream solutions for improving lentiviral workflows
Webinar
This webinar explores how a set of upstream products for tranisient lentiviral production can be used in concert to achieve significant improvements in lentiviral titers with minimal optimization.
In this webinar, you will learn:
- How to maximize functional titers with lentiviral upstream solutions compared to standard industry offerings.
- How you can streamline lentiviral upstream process development and minimize the need for extensive optimization of transfection reagents and media by choosing solutions that are designed to work together.
- How Lentivirus titer and particle size are controlled with VirusGEN® Stabilizer.
- Key learnings for successful scale up of transient lentiviral processes to bench-scale stirred-tank bioreactors.
Speakers
Benjamin Ross-Johnsrud
Merck
R&D Manager, Focused Modality Applications
Benjamin Ross-Johnsrud is an Upstream R&D Manager in Focused Modality Applications for Process Solutions at our company, in his current role he focuses on leading a team in analytical development, process development, and automation to establish capabilities in novel modalities. Over his seven-year tenure at our company and fourteen years in the biopharmaceutical industry he has held multiple R&D and field applications roles, enjoying both the development and deployment of novel technologies into Biopharmaceutical and Cell and Gene Therapy unit operations.
William Tang
Merck
R&D Scientist Ⅱ, Focused on VGT Platform
William Tang has been a Scientist at our company for 7 years, based in the PMC RD team in Shanghai, China. He focuses on novel modality platform development. His scope includes technical support for HEK293 and insect cell catalog solutions for customers, as well as the development of customized media and upstream processes for AAV, LV, VLP and vaccine production.
William holds a Master’s degree in Bioengineering from East China University of Science and Technology.
Pharma and biopharma manufacturing
- Cell therapy manufacturing
Duration:1h
Language:English
Session 1:Thu, November 19, 2026 3:00 PM CEST